21 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1548

Genscript Biotech
HK$10.18-11.5%-55.0%HK$21.8bHK$23.34PS2.8xE112.7%0%

2228

QuantumPharm
HK$4.08-23.7%n/aHK$13.9bHK$10.35PS65.6xE88.9%n/a

6826

New
Shanghai Haohai Biological Technology
HK$27.00-6.9%-14.1%HK$13.9bHK$42.57PE13.5xE16.8%3.2%

9969

New
InnoCare Pharma
HK$6.16-10.1%-11.0%HK$12.9bHK$9.34PS11.2xE7.3%n/a

2005

SSY Group
HK$3.73-1.8%-25.1%HK$11.0bHK$6.16PE8.1xE5.8%4.8%

3613

New
Beijing Tong Ren Tang Chinese Medicine
HK$7.85-3.1%-39.2%HK$6.6bHK$12.05PE13.3xE16.5%4.2%

2877

China Shineway Pharmaceutical Group
HK$8.13-3.3%15.2%HK$6.1bHK$12.82PE5.2xE8.3%6.9%

2157

Lepu Biopharma
HK$2.81-11.9%-27.4%HK$4.8bHK$5.00PS21.8xS65.6%n/a

1477

Ocumension Therapeutics
HK$5.191.8%-28.0%HK$4.2bHK$9.92PS12.7xE101.9%n/a

2179

Jiangsu Recbio Technology
HK$8.302.1%-28.9%HK$4.0bHK$13.00PS85.3xE38.2%n/a

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$7.30-4.2%-74.9%HK$2.7bHK$16.39PS348.7xS-81.8%n/a

2256

Abbisko Cayman
HK$4.18-3.9%14.8%HK$2.6bHK$9.20PS4.9xE-41.7%n/a

2487

Cutia Therapeutics
HK$8.34-8.4%-58.1%HK$2.6bHK$14.72PS11.9xE49.4%n/a

2315

Biocytogen Pharmaceuticals (Beijing)
HK$5.67-7.0%-55.9%HK$2.3bHK$13.28PS2.6xS22.4%n/a

1167

Jacobio Pharmaceuticals Group
HK$1.54-11.0%-62.4%HK$1.2bHK$3.70PS48.8xS-2.4%n/a

6622

Zhaoke Ophthalmology
HK$1.35-3.6%-68.2%HK$737.3mHK$2.50PS12xE11.7%n/a

2126

JW (Cayman) Therapeutics
HK$1.32-0.8%-48.0%HK$534.0mHK$2.40PS2.9xE-1.8%n/a

9939

Kintor Pharmaceutical
HK$1.07-3.6%-68.4%HK$463.3mHK$14.15PB1.1xE25.8%n/a

6996

Antengene
HK$0.66-8.3%-62.5%HK$448.4mHK$1.69PS7.4xE17.0%n/a

6628

Transcenta Holding
HK$0.77-12.5%-77.4%HK$311.7mHK$8.77PS13xE12.7%n/a

2257

Sirnaomics
HK$2.600.4%-94.5%HK$225.7mHK$72.10PS26.9xS63.5%n/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.